Bank of America Corporation (BAC) entered the fourth quarter of 2026 trading near $51.75, having declined about 5.8% over the prior 30 days and roughly 16% from its late-July levels near $62. The pullback came despite resilient underlying banking fundamentals, reflecting investor unease around a one-time regulatory settlement, a softer capital-markets quarter, and broader repositioning in large-cap bank stocks. The shares remain well above the 52-week low of $46.12 and below the 52-week high of $65.23, with analysts maintaining a median 12-month price target near $66. I checked recent price action using Tickeron’s AI Pattern Search Engine to put the move in context with similar bank names.
Bank of America is one of the world's largest financial institutions and the second-largest U.S. bank holding company by assets. It serves roughly 69 million consumer and small-business clients and operates through four main segments: Consumer Banking, Global Wealth & Investment Management (including Merrill), Global Banking, and Global Markets. Its diversified model spans retail deposits, credit cards, commercial and corporate lending, wealth management, and institutional sales and trading. A low-cost deposit franchise, strong digital engagement through platforms such as Erica, and a leading wealth-management business are widely viewed as competitive advantages. Investors follow BAC closely as a bellwether for U.S. consumer health, credit conditions, and interest-rate sensitivity across the banking sector.
The dominant event of the past month was third-quarter earnings on October 14, 2026. The bank reported GAAP net income of $6.9 billion, or $0.91 per share, down from $8.3 billion a year earlier, reflecting a non-tax-deductible $1.2 billion regulatory settlement charge related to deficiencies in its anti-money-laundering and economic-sanctions compliance programs. Excluding the charge, net income was $8.1 billion, or approximately $1.08 per share.
Beneath the headline, the core franchise remained strong. Revenue rose about 3% year over year to $30.0 billion, while net interest income climbed 8% to $16.6 billion on higher loan and deposit balances and fixed-rate asset repricing, with the net interest yield improving to 2.16%. Ending loans grew to $1.25 trillion and deposits to $2.04 trillion. Credit quality stayed stable, with a $1.3 billion provision for credit losses.
Softer areas included sales and trading revenue, which fell 5% to $5.1 billion, as fixed-income revenue declined 17% amid rate volatility, and investment banking fees, which slipped 11% to $1.8 billion. Management returned $8.3 billion to shareholders through dividends and $6 billion in buybacks, and its common equity tier 1 ratio remained solid at 10.9%. The stock slid more than 5% on the earnings day before stabilizing, with the settlement and a modest earnings miss outweighing an upbeat long-term net interest income outlook. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Looking ahead, several factors are likely to shape BAC shares through the remainder of 2026 and into 2027. Management's guidance for roughly 8% net interest income growth in 2026, and 8% or more in 2027, hinges on modest loan and deposit growth, continued fixed-rate asset repricing, and the Federal Reserve's rate path. Higher rates support asset-sensitive earnings but can pressure fixed-income trading revenue and investment banking activity.
Investors will also monitor the bank's expense trajectory and its return to operating leverage, particularly as technology and compliance investments continue. The resolution of the AML remediation effort, final Basel III endgame capital rules, and a scheduled G-SIB surcharge step-up in early 2027 could influence the pace of share buybacks. Credit quality, consumer spending trends, and wealth-management flows remain key indicators of the health of the core franchise.
When evaluating names like BAC, I often turn to Tickeron’s Trending AI Robots for a systematic perspective. The platform highlights top-performing automated strategies across various timeframes and risk profiles, which can complement traditional analysis when considering sector trends or individual stock behavior. It has become a regular part of how I cross-check ideas without replacing my own judgment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
BAC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 20, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 33 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 69%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BAC as a result. In 43 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.
The 50-day moving average for BAC moved below the 200-day moving average on November 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The Aroon Indicator for BAC entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for BAC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAC advanced for three days, in 212 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
BAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 2 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.252) is normal, around the industry mean (1.500). P/E Ratio (11.232) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (0.873) is also within normal values, averaging (2.139). Dividend Yield (0.026) settles around the average of (0.035) among similar stocks. P/S Ratio (3.643) is also within normal values, averaging (3.867).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. BAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 79 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 26, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks